|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| C07D 403/14 | |||
| C07D 413/14 | |||
| C07D 417/14 | |||
| C07D 487/04 | |||
| C07D 498/04 | |||
| A61K 31/496 | |||
| A61P 1/00 | |||
| A61P 3/10 | |||
| A61P 3/00 | |||
| A61P 19/00 | |||
| A61P 25/00 |
| (11) | Number of the document | 2116541 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09166645.3 |
| Date of filing the European patent application | 2005-04-29 | |
| (97) | Date of publication of the European application | 2009-11-11 |
| (45) | Date of publication and mention of the grant of the patent | 2015-02-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 570300 P | 2004-05-12 | US | |
| 664305 P | 2005-03-21 | US |
| (72) |
Hulin, Bernard, US
Piotrowski, David, Walter, US
|
| (73) |
Pfizer Products Inc.,
Eastern Point Road, Groton, CT 06340,
US
|
| (54) | Proline derivatives and their use as dipeptidyl peptidase IV inhibitors |
| Proline derivatives and their use as dipeptidyl peptidase IV inhibitors |